European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- _hot_ -

: Since January 2018, revised standards mandate a suitable dissolution test for immediate-release forms unless otherwise justified.

For immediate-release tablets, this test measures the time required for a tablet to break down into particles. The apparatus uses a basket-rack assembly moving up and down in a liquid medium.

: Formulated to be easily crushed by chewing before swallowing, avoiding the immediate need for a disintegration test. Key Technical and Analytical Requirements

: The formulation must exhibit sufficient mechanical strength to withstand the physical friction of packaging, shipping, and automated dispensing without fracturing. Strict Requirements for Scored Tablets (Subdivision) The Ph.Eur. approach to tablet splitting

A 2020 European study found many tablets failed Ph. Eur. divisibility requirements. The Freedom of Information request regarding UK liothyronine tablets further demonstrates the practical consequences of non-compliance with these rules. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

Revised in Supplement 9.3, this requires that break-marks be functional. If used for fractional dosing, the subdivided parts must meet strict uniformity of mass standards (e.g., 30 parts tested; most must be within 85–115% of average mass).

30 tablets are broken by hand. One part from each is weighed.

Beyond the technicalities, Elena reflected on the monograph’s voice. It was precise, sometimes austere, but never arbitrary. Each requirement had been argued into existence by experts, trials, and consensus. The Ph. Eur. committees were an ecosystem of national authorities, industry scientists, clinicians, and patient representatives. That consensus made the monograph legally influential in many countries, shaping regulations and inspections. For manufacturers, it was both roadmap and yardstick; for regulators, a harmonizing tool; for patients, the invisible guarantee behind a blister pack.

Monograph 0478 defines as solid preparations containing a single dose of one or more active substances, obtained by compressing uniform volumes of particles or by other techniques like extrusion, moulding, or freeze-drying (lyophilisation). It applies primarily to tablets for oral administration but excludes lozenges, oral pastes, and oral gums. In some cases, the requirements may not apply to tablets for veterinary use when justified and authorised. : Since January 2018, revised standards mandate a

: For scored tablets, the monograph requires that break-marks be functional. If a tablet is meant to be split for a fractional dose, it must meet specific criteria for the uniformity of mass of the subdivided parts Modern Updates and Compliance

(prolonged, delayed, or pulsatile release) Gastrorisistant tablets (enteric-coated)

: Uncoated tablets must typically disintegrate within 15 minutes in water at 37°C. Coated tablets (non-film) are allowed up to 60 minutes.

The "Tablets -0478-" monograph is essential for manufacturers, regulators, and control laboratories involved in the development, production, and quality control of tablets. The monograph provides a comprehensive framework for evaluating the quality of tablets and ensures that medicinal products available to patients in Europe meet the required standards. : Formulated to be easily crushed by chewing

Pharmaceutical manufacturing operates on a global scale, making regulatory alignment highly desirable. The EDQM actively participates in the alongside the United States Pharmacopeia (USP) and the Japanese Pharmacopoeia (JP).

To achieve compliance under Ph. Eur. 0478, batch testing must rigorously fulfill a series of physical and analytical parameters. These general chapters dictate the core quality targets for standard tableting processes. 1. Disintegration (Ph. Eur. 2.9.1)

: The batch complies only if no more than 1 split unit out of 30 falls outside 85% to 115% of the average mass. The batch completely fails if more than one part deviates or if any single part falls outside 75% to 125% of the average mass. Crucial Quality Control (QC) Testing Standards

: Formulations covered with one or more layers of mixtures (sugars, resins, waxes, or authorized polymers) to protect the API or mask unpleasant tastes.